• Post diploma DNB from Seth G.S. Medical College & KEM Hospital, Mumbai.
• Diploma in Radiation Medicine (DRM) from Institute of Nuclear medicine and allied sciences, Delhi.
• MBBS from Dalian Medical University, China.

• An apprenticeship of 6 months in nuclear medicine technology (SPECT and PET), health physics, medical cyclotron and radiopharmacy.
• Handling, preparation and injection of various ^99mTc, ¹⁸F and ⁶⁸Ga
• Acquiring and reporting a wide range of SPECT scans with ^99mTc-labelled and ¹³¹I based radiopharmaceuticals.
• Obtaining and detailing of PET/CT scans (¹⁸F-FDG, ¹⁸F-NaF, ⁶⁸Ga-DOTATATE, ⁶⁸Ga-PSMA, ¹⁸F-FLT, ¹⁸F-FET, ¹¹C- Methionine, etc) in numerous oncological as well as non-oncological indications.
• Dealt with thyroid OPD (history taking, physical examination and prescription of thyroid drugs) consisting of plentiful cases of hypothyroidism, thyrotoxicosis and carcinoma thyroid.
• Selected and prescribed appropriate radionuclides and dosages for administration.

• Working as Consultant Nuclear Medicine at Prathima Cancer Institute from March 2023
• Worked as consultant Nuclear Medicine at Sprint Diagnostics from July 2022 to March 2023
• Worked as consultant Nuclear Medicine at Americal Oncology Institute from January,2022 to July 2022
• Worked as Senior Resident at Safdarjung Hospital from October 2018 to May 2019
• Worked as Senior Resident at Delhi State Cancer Institute from May 2018 to September 2018

• An apprenticeship of 6 months in nuclear medicine technology (SPECT and PET), health physics, medical cyclotron and radiopharmacy.
• Handling, preparation and injection of various ^99mTc, ¹⁸F and ⁶⁸Ga
• Acquiring and reporting a wide range of SPECT scans with ^99mTc-labelled and ¹³¹I based radiopharmaceuticals.
• Obtaining and detailing of PET/CT scans (¹⁸F-FDG, ¹⁸F-NaF, ⁶⁸Ga-DOTATATE, ⁶⁸Ga-PSMA, ¹⁸F-FLT, ¹⁸F-FET, ¹¹C- Methionine, etc) in numerous oncological as well as non-oncological indications.
• Dealt with thyroid OPD (history taking, physical examination and prescription of thyroid drugs) consisting of plentiful cases of hypothyroidism, thyrotoxicosis and carcinoma thyroid.
• Selected and prescribed appropriate radionuclides and dosages for administration.
• • Acquisition and reporting of diagnostic SPECT/CT and PET/CT scans.
  • Trainee (June 2019)- CT Scan -Department of Radiology,  KEM Hospital Mumbai.
  • Trainee (July 2019)- Department of Nuclear Medicine,Tata Memorial Hospital, Mumbai.
  • Trainee (July 2021)- Therapy posting, Department of Nuclear Medicine, Radiation Medicine Center, Mumbai.

  # Evaluation and therapy in cases of Neuroendocrine tumours and Prostate carcinoma for PRRT and ¹⁷⁷Lu-PSMA therapy.

  # Administration of ¹³¹I-NaI (maximum dose given to a patient is 250 mCi) and monitoring patients of carcinoma thyroid, thyrotoxicosis and protocol for Inj rhTSH administration.

  #  Injection of ¹⁷⁷Lu-DOTATATE and monitoring of patients post PRRT.

  #. Handling and administration of ¹³¹I-MIBG.

  Assisted with clean-up of radioactive spills and execution of decontamination activities.

• Therapeutic and diagnostic Nuclear Medicine

  • SPECT/CT and PET/CT imaging
  • Thyroid carcinoma
  ¹³¹ I- radiation ablation therapy, ¹³¹ I- MIBG therapy, ¹⁷⁷ Lu PRRT and ¹⁷⁷ Lu PSMA therapy

Acquisition and reporting of diagnostic SPECT/CT and PET/CT scans.

• • Trainee (June 2019)- CT Scan -Department of Radiology,  KEM Hospital Mumbai.
  • Trainee (July 2019)- Department of Nuclear Medicine,Tata Memorial Hospital, Mumbai.
  • Trainee (July 2021)- Therapy posting, Department of Nuclear Medicine, Radiation Medicine Center, Mumbai.

  • # Evaluation and therapy in cases of Neuroendocrine tumours and Prostate carcinoma for PRRT and ¹⁷⁷Lu-PSMA therapy.

    # Administration of ¹³¹I-NaI (maximum dose given to a patient is 250 mCi) and monitoring patients of carcinoma thyroid, thyrotoxicosis and protocol for Inj rhTSH administration.

    #  Injection of ¹⁷⁷Lu-DOTATATE and monitoring of patients post PRRT.

    #. Handling and administration of ¹³¹I-MIBG.

    Assisted with clean-up of radioactive spills and execution of decontamination activities.